Long-term extracellular matrix metabolism by cultured human osteogenesis imperfecta osteoblasts

Journal of Bone and Mineral Research

Volumn 11, Issue 6, 1996, Pages 800-805

  Fedarko, Neal S ^a   Sponseller, Paul D ^a   Shapiro, Jay R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; HYALURONIC ACID; OSTEONECTIN; PROTEOGLYCAN;

ARTICLE; COLLAGEN METABOLISM; COLLAGEN SYNTHESIS; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOGENESIS IMPERFECTA; OSTEOPENIA; PROTEIN METABOLISM;

EID: 0029900432     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650110611     Document Type: Article

References (22)

1. Cole WG 1994 Osteogenesis imperfecta as a consequence of naturally ocurring and induced mutations of type I collagen. Bone Miner Res 8:167-204.
2. Fedarko N, Moerike M, Brenner R, Gehron Robey P, U Vetter 1992 Extracellular matrix formation by osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res 1992 7:921-930.
3. Fedarko NS, Gehron Robey P, Vetter U 1995 Extracellular matrix stoichiometry in osteoblasts from patients with osteogenesis imperfecta. J Bone Miner Res 10:1122-1129.
4. Fedarko NS, D'Avis P, Frazier CR, Burrill MJ, Fergusson V, Tayback M, Sponseller PD, Shapiro JR 1995 Cell proliferation of human fibroblasts and osteoblasts in osteogenesis imperfecta: Influence of age. J Bone Miner Res 10:1705-1712.
5. Gehron Robey P, Termine JD 1985 Human bone cells in culture. Calcif Tissue Int 37:453-460.
6. Fedarko NS, Vetter UK, Weinstein S, Gehron Robey P 1992 Age-related changes in hyaluronan, proteoglycan, collagen and osteonectin synthesis by human bone cells. J Cell Physiol 151: 215-227.
7. Fedarko NS, Conrad HE 1986 A unique heparan sulfate in the nuclei of hepatocytes: structural changes with growth state of the cells. J Cell Biol 102:587-599.
8. Aronow MA, Gerstenfeld LC, Tassinari MS, Stein GS, Lian JB 1990 Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143: 213-221.
9. Owen TA, Aronow MA, Shalhoub V, et al. 1990 Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvarial cells. J Cell Physiol 143:420-431.
10. Fedarko NS, Termine JD, Young MF, Gehron Robey P 1990 Temporal regulation of hyaluronan and proteoglycan metabolism by human bone cells in vitro. J Biol Chem 265:12200-12209.
11. Stein GS, Lian JB, Owen TA 1990 Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4:3111-3123.
12. Gehron Robey P, Bianco P, Termine JD 1991 The cell biology and molecular biochemistry of bone formation. In: Favus MJ, Coe F (eds.) Disorders of Bone and Mineral Metabolism. Raven Press, New York, NY, U.S.A., pp. 241-263.
13. Gerstenfeld LC, Chipman SD, Clowarcki J 1988 Expression of differentiated function by mineralizing cultures of chicken osteoblasts. J Cell Biol 106:979-989.
14. Bianco P, Riminucci M, Silvestrini G, Bonucci E, Termine JD, Fisher LW, Robey PG 1993 Localization of bone sialoprotein (BSP) to Golgi and post-Golgi secretory structures in osteoblasts and to discrete sites in early bone matrix. J Histochem Cytochem 41(2):193-203.
15. Oohira A, Nogami H 1989 Elevated accumulation of hyaluronate in the tubular bones of osteogenesis imperfecta. Bone 10:409-413.
16. Greally JM, Boone LY, Lenkey SG, Wenger SL, Steele MW 1992 Acrometageria: a spectrum of "premature aging" syndromes. Am J Med Genet 44:334-339.
17. Salk D, Fujiwara Y, Martin GM 1985 Proteoglycans in the Werner syndrome and aging: a review and perspective. In: Advances in Experimental Medicine and Biology, Vol 190. Plenum Press, New York, NY, U.S.A., pp. 553-565.
18. Mast BA, Haynes JH, Krummel TM, Diegelmann RF, Cohen IK 1992 In vivo degradation of fetal wound hyaluronic acid results in increased fibroplasia, collagen deposition and neovascularization. Plast Reconstruct Surg 89:503-509.
19. Glimcher MJ 1990 The nature of the mineral component of bone and the mechanism of calcification. Alveoli LV, Krane SM (eds.) In: Metabolic Bone Diseases. W.B. Saunders Company, Philadelphia, PA, U.S.A., pp. 43.
20. Casella JP, Ali FY 1992 Abnormal collagen and mineral formation in OI. Bone Miner 17:123-128.
21. Smith R, Francis, MJO, Houghton GR 1983 The Brittle Bone Syndrome: Osteogenesis Imperfecta. Butterworths, London, U.K., pp. 82.
22. Shapiro JR, McCarthy EF, Earnest K, Copley C, Rossiter K 1995 Bone turnover is low in type I osteogenesis imperfecta. J Bone Miner Res 10(suppl):S602.